Pharmaceutical services provider Parexel is set to create more clinical research jobs over the coming months.
In its latest financial report, the organisation's chairman and chief executive officer Josef von Rickenbach stated that it will be aiming to accelerate the recruitment of direct labour staff for its clinical research services division.
He said this is taking place due to the performance and expected growth of the business, with Parexel's consolidated service revenue growing by 3.5 per cent year-on-year in Q3 2010-11 to reach a total of $301.4 million (£182.39 million).
Mr von Rickenbach expressed confidence that this improved performance and ramp-up in hiring will drive a mid-teens growth in revenue during the second half of its current fiscal year.
"This is an exciting time for our industry and we believe that we are well-positioned to continue to increase our share of the market," he said.
Earlier this year, the company was chosen by Merck Sharpe and Dohme to provide assistance into new clinical research initiatives in the field of biosimilars.